Green Lantern Capital PMS: Strategy, Returns & Risk Profile

Every fund has an origin story, and Green Lantern's begins in December 2016, when Nilesh Doshi and Abhishek Bhardwaj incorporated Green Lantern Capital LLP. The firm secured its SEBI Portfolio Management Services licence and formally launched operations a year later, in December 2017, with the Growth Fund as its first strategy (as detailed on the firm's own About page). The founding idea was deliberately unglamorous: build "a process-led investment institution focused on disciplined research, strong governance, and long-term value creation."

That timing matters. Green Lantern was born just as India's PMS industry was maturing into a serious, institution-grade category. In November 2019, the market regulator doubled the minimum PMS investment from ₹25 lakh to ₹50 lakh, a move that Business Standard reported alongside tighter disclosure norms. The Securities and Exchange Board of India (SEBI) has since pushed the entire category toward standardised reporting, cleaner fee disclosure, and — from 2025 — mandatory APMI registration for distributors. For a governance-first boutique, this tightening was a tailwind, not a headwind: it rewarded exactly the kind of transparency Green Lantern claims to be built on.

Since inception, the firm has grown into a genuine mid-sized boutique. As of 30 June 2026, Green Lantern manages approximately ₹1,800 crore across its two strategies for around 1,379 clients, according to data aggregated by PMS Bazaar. That is small enough to stay nimble in the small-cap space — where a giant fund cannot deploy meaningfully without moving prices — yet large enough to signal that clients and capital have stuck around.

A PMS is only ever as good as the humans making the calls, so the management bench deserves scrutiny.

• Nilesh Doshi — CEO & Managing Partner. A Chemical Engineering graduate from IIT Bombay with 30+ years across industry and capital markets, Doshi began his career at Pidilite before moving into equity research and institutional sales. He sets the strategic vision and hunts for sectors at inflection points.
• Abhishek Bhardwaj — Managing Partner, Principal Officer & Fund Manager. A Chartered Accountant with 19+ years in equity markets, Bhardwaj has previously worked at Reliance Mutual Fund and as an Equity Fund Manager at Star Union Dai-Ichi Life Insurance. He owns portfolio construction and regulatory oversight.
• Pradeep Gokhale — Partner & Fund Manager (joined 2023). A CA and CFA charterholder with 23+ years, Gokhale was formerly Head of Equity at ITI Asset Management and spent 15+ years at Tata Asset Management — a heavyweight addition to the research engine.
• Nitin Pandey — Partner & Head of Business Development (joined 2020). Brings experience from Reliance Capital Asset Management, Edelweiss, and a USD 2 billion global family office.

That is a deep, institutionally-trained team for a boutique — and it is the kind of manager tenure and pedigree that any serious due-diligence process weighs before the returns.

Here is where most competitor pages stop at two words — "small-cap" — and move on. The strategy deserves more.

Green Lantern describes its investment philosophy as grounding every decision in intrinsic-value assessment and risk-reward discipline, seeking "scalable businesses with good governance standards, competitive advantages, and sustainable return profiles." In practice, that translates into a quality-growth approach: the team is not buying cheap, broken companies hoping for a bounce; it is buying businesses it believes can compound earnings for years, then holding them.

The process blends top-down and bottom-up analysis — identifying macroeconomic and sectoral trends that are inflecting, then drilling into individual companies that should ride those trends. The goal is alpha: return above what the benchmark delivers. (If you are new to the term, Investopedia's primer on alpha is a clean explainer.)

The Growth Fund is explicit about where it plays: it targets 75%–100% of the portfolio in mid- and small-cap equities, with only 0%–25% parked in large caps. Its yardstick is the S&P BSE 500 Total Return Index (TRI) — a broad benchmark maintained under the BSE index family, which captures roughly the top 500 listed companies and, in TRI form, includes dividends reinvested.

This is a crucial design choice. Small- and mid-cap companies are where the biggest multi-baggers hide — but also where the sharpest falls happen. By deliberately anchoring the book in that segment rather than diluting it with defensive large caps, Green Lantern is making a clear bet: that disciplined stock-picking in India's under-researched small-cap universe can beat the index over a full cycle. The five-year record suggests it has — but as we will see, "over a full cycle" is doing a lot of work in that sentence.

Because a PMS gives you direct ownership of the underlying stocks in your own demat account — unlike a mutual fund, where you own units of a pool — you can see exactly which businesses the team backs. That transparency is a genuine feature, and it is one reason many investors "graduate" from mutual funds to PMS. (If you are weighing that jump, this explainer on what PMS is and how it differs from mutual funds is a useful starting point.)

Green Lantern's second strategy, the Alpha Fund (live since February 2020), dials the risk down a notch. It focuses on established mid- and large-cap businesses with strong balance sheets and consistent cash flows — the kind of companies that wobble less when small caps get sold off hard. For an investor who wants Green Lantern's process but with a smoother ride, the Alpha Fund is the more conservative expression of the same philosophy. It is also much smaller, at roughly ₹63 crore in assets versus the Growth Fund's near-₹1,770 crore.

A few things jump out. First, the three- and five-year records are genuinely strong — a ~34–35% CAGR over half a decade for the Growth Fund is well above what the broad market delivered over the same window, and the firm's own materials frame this as roughly a 4.3x multiple over five years versus about 1.8x for the benchmark. In a standout year like FY25, the Growth Fund returned about 24.62% against a benchmark near 6.7%. That is real outperformance, and it is why the strategy has collected industry awards for risk-adjusted returns in the small- and mid-cap category.

Second — and this is the part the aggregator pages tend to bury — the one- and two-year numbers are far more modest. An 8.56% one-year return sits a world away from the triple-digit figures some stale web pages still display from the frenzied 2021–2024 small-cap run. That gap is not a red flag; it is simply what small-cap investing looks like once a hot cycle cools. Which brings us to the single most important discipline in reading any PMS track record.

Here is the trap. If you had searched "Green Lantern Capital returns" during the small-cap mania, you would have seen one-year figures north of 100% and concluded you had found a money machine. Anchor on that, invest at the top, and your actual experience would have been the 8.56% — or worse, a drawdown — that followed. Trailing returns are a rear-view mirror, and small-cap rear-view mirrors are especially distorted.

The honest way to evaluate a strategy like this is to look at the full-cycle CAGR, not the best twelve months; to compare it against the right benchmark (the S&P BSE 500 TRI, not the Nifty 50); and to weigh the return against the risk taken to earn it. A 35% CAGR earned with wild 50% drawdowns is a very different product from a 35% CAGR earned with a beta of around 0.7 — which is what Green Lantern's Growth Fund reports, meaning it has historically moved less than one-for-one with the market.

This is precisely the kind of cross-checking that is hard to do from a single marketing page — and exactly where an independent, data-driven second opinion earns its keep. Platforms like PMS Sahi Hai and its AI engine Nyra exist to score a strategy across standardised pillars — returns, risk, fees, manager tenure, concentration, transparency and AUM fit — so the headline number never gets to stand alone. More on that shortly.

If you take one section seriously, make it this one. The returns are the reward; the risk profile is the price.

Green Lantern's Growth Fund is, by construction, a high-volatility, high-conviction, small-and-mid-cap-concentrated portfolio. Every word in that phrase is a risk factor:

• High volatility. Small and mid caps swing harder than large caps in both directions. Broad Indian small-cap indices have historically delivered spectacular multi-year runs punctuated by brutal corrections — the kind that test conviction and account statements alike. Coverage from outlets like The Economic Times markets desk and Moneycontrol regularly documents how quickly small-cap sentiment can turn.
• Drawdown risk. A drawdown is the peak-to-trough fall before a new high is reached (definition here). Concentrated small-cap books can and do experience drawdowns of 30% or more in a bad cycle. The cooling from triple-digit one-year returns to single digits by mid-2026 is a live illustration.
• Concentration risk. "High-conviction" means fewer stocks and bigger position sizes. When the calls are right, that concentration supercharges returns; when a large position is wrong, it hurts disproportionately.
• Beta and market sensitivity. The reported 1-year beta of ~0.7 is actually reassuring — it suggests the manager has historically dampened, not amplified, market moves (what beta measures). But beta is backward-looking and can shift; it is a clue, not a guarantee.

The practical implication is about position sizing and horizon, not avoidance. A small-cap PMS like this is designed to be one sleeve of a diversified portfolio, held for a genuinely long horizon — ideally seven years or more so it can ride through at least one full boom-and-bust cycle. It is emphatically not a place to park money you might need in two years, and not a capital-preservation vehicle.

There is also liquidity and lock-in to consider. PMS investments typically carry exit loads in the early years (industry-standard structures, and Green Lantern's reported schedule, taper from around 3% in year one to nil by year three), and small-cap holdings themselves can be harder to exit in size during a stampede. In short: the strategy asks for patience and a strong stomach, and it penalises the impatient.

Weighing all of the above, here is the honest bull case.

1. A genuine small- and mid-cap specialism. This is not a watered-down all-cap fund. The 75–100% mid/small-cap mandate gives real, undiluted exposure to India's emerging leaders — the segment with the highest long-term compounding potential.
2. A strong, multi-cycle track record. A ~35% three-year and ~34% five-year CAGR (as of 30 June 2026), well ahead of the S&P BSE 500 TRI, is a meaningful record for a boutique — and it was earned with a sub-1 beta, suggesting the outperformance came from stock-picking rather than simply cranking up risk.
3. A deep, credentialled team. IIT Bombay, multiple Chartered Accountants, a CFA charterholder, and alumni of Tata AMC, Reliance MF and ITI AMC — the bench has both the analytical firepower and the market scar tissue that small-cap investing demands.
4. A process-and-governance-led philosophy. Decisions are anchored in intrinsic value and risk-reward discipline, not star-manager instinct — a repeatable framework that is more likely to survive market cycles and personnel changes.
5. Transparency and choice. As a PMS, you get direct ownership of the stocks in your demat account and full visibility of holdings, plus a choice between the aggressive Growth Fund and the steadier Alpha Fund — or a blend calibrated to your risk appetite.

No strategy is a free lunch, and a piece that only lists advantages is a brochure, not analysis. Here are the real limitations.

1. Volatility and drawdown are structural, not occasional. The very concentration that drives the upside guarantees a bumpy ride. The slide from triple-digit peak-cycle returns to a single-digit one-year figure by mid-2026 is the strategy behaving exactly as designed — and many investors underestimate how uncomfortable that feels with real money on the line.
2. A high, exclusionary entry barrier. The ₹50 lakh SEBI-mandated minimum puts this out of reach for most investors, and even for HNIs it represents a serious, illiquid commitment with early-exit loads. This is patient, long-horizon capital only.
3. Fee drag eats into net returns. PMS fee structures — commonly a fixed fee around 2.5%, or a performance-sharing model near 10% above an ~8% hurdle, plus 18% GST — compound against you. A strong gross return can look far more ordinary net of fees, so always evaluate net outcomes.
4. Key-person and concentration dependence. The strategy's edge is tied to a small senior team and a concentrated book. That is a double-edged sword: it is the source of the alpha and a genuine single-point-of-failure risk if a key manager departs or a big position blows up.

Here is the quiet truth about choosing a PMS: the headline return is the easy part. The inner clause — the risk, the fee drag, the concentration, the overlap with what you already own — is where hard-earned wealth is won or lost. And that inner clause is almost never on the marketing page.

This is the exact problem PMS Sahi Hai was built to solve. As India's 1st AI-powered PMS & AIF marketplace, it exists to do one thing: help you compare, evaluate and invest in PMS and AIF — smarter and faster — with advice that answers to you, not to a commission. It is a SEBI-registered distributor and advisor, and it is trusted by HNIs, NRIs and family offices across India precisely because it treats the fine print as the main event.

At the heart of the platform is Nyra — your AI Wealth Compass. Nyra tracks 1,000+ PMS and AIF strategies in real time and scores each one across the pillars that actually decide outcomes: returns, risk, fees, manager tenure, concentration, transparency and AUM fit. For a strategy like Green Lantern Capital's Growth Fund, that means you never have to take a 35% CAGR at face value again. Nyra places it next to its beta, its drawdown behaviour, its fee structure, and — critically — the overlap it may have with the small-cap mutual funds or stocks you already hold. Because the fastest way to accidentally double your risk is to buy a "new" strategy that owns the same names you already do.

Nyra's approach is refreshingly practical:

• Profile & Goals — it starts with your risk appetite, horizon and goals, not a product it wants to sell.
• Analyze Your Portfolio — it reveals hidden overlap, sector concentration and duplication across everything you own.
• Curated PMS & AIF Match — its research engine filters 1,000+ strategies to the handful that genuinely fit you.
• Smart Investing — compare and evaluate strategies like Green Lantern's side by side, then invest directly.
• Continuous Monitoring — it keeps watching sector shifts and liquidity, and flags when it is time to rebalance.

The philosophy is simple and it is the right one: hard-earned wealth shouldn't rely on random advice. Whether Green Lantern Capital belongs in your portfolio depends on your existing holdings, your risk tolerance and your horizon — and that is a question of fit, which is exactly what an independent engine like Nyra is designed to answer. If you are also exploring the AIF route, the same logic applies, and PMS Sahi Hai's guide to Alternative Investment Funds is a good companion read.